RecruitingPhase 4NCT05302999

Feasibility of Early Gabapentin as an Intervention for Neurorecovery

Sponsor

MetroHealth Medical Center

Enrollment

42 participants

Start Date

Mar 14, 2022

Study Type

INTERVENTIONAL

Conditions

Spinal Cord Injuries

Summary

The objective of the proposed study is to conduct the first ever prospective, dose-exploration trial to test the feasibility of early administration of gabapentin as an intervention for neurorecovery. This research project falls under the Intervention Development stage of research as the primary goal is to assess the feasibility of conducting a well-designed intervention efficacy study in the future.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Gabapentin and a drug called Placebo for people with spinal cord injuries. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.